Development of a diagnostic microarray assay to assess the risk of recurrence of prostate cancer based on PITX2 DNA methylation.
about
DNA Methylation of PITX2 and PANCR Is Prognostic for Overall Survival in Patients with Resected Adenocarcinomas of the Biliary TractPerformance evaluation of kits for bisulfite-conversion of DNA from tissues, cell lines, FFPE tissues, aspirates, lavages, effusions, plasma, serum, and urine.Clinical performance validation of PITX2 DNA methylation as prognostic biomarker in patients with head and neck squamous cell carcinoma.Bisulfite Conversion of DNA from Tissues, Cell Lines, Buffy Coat, FFPE Tissues, Microdissected Cells, Swabs, Sputum, Aspirates, Lavages, Effusions, Plasma, Serum, and Urine.Biomarkers in prostate cancer epidemiology.PITX3 DNA methylation is an independent predictor of overall survival in patients with head and neck squamous cell carcinoma.Diagnostic and prognostic molecular biomarkers for prostate cancer.Nucleic acid-based tissue biomarkers of urologic malignancies.Prognostic DNA methylation markers for prostate cancer.Large-scale evaluation of SLC18A2 in prostate cancer reveals diagnostic and prognostic biomarker potential at three molecular levelsPITX3 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients after radical prostatectomy.Comprehensive Evaluation of TFF3 Promoter Hypomethylation and Molecular Biomarker Potential for Prostate Cancer Diagnosis and Prognosis.Development and clinical validation of a real-time PCR assay for PITX2 DNA methylation to predict prostate-specific antigen recurrence in prostate cancer patients following radical prostatectomy.Intragenic DNA methylation of PITX1 and the adjacent long non-coding RNA C5orf66-AS1 are prognostic biomarkers in patients with head and neck squamous cell carcinomas.[Molecular biomarkers and prognostic factors for prostate cancer].Evaluation of ZAR1 and SFRP4 methylation status as potentials biomarkers for diagnosis in cervical cancer: exploratory study phase I.Evaluation of bisulfite kits for DNA methylation profiling in terms of DNA fragmentation and DNA recovery using digital PCR.
P2860
Q28109676-63FD3E74-8EE3-475A-A71C-A8E93BEA5B63Q31157538-6B9DCBFA-57E5-496A-93A5-158F9DE39DA9Q33803297-E42DA6B0-3ED4-4037-95DF-C2E2089EDFCDQ35681956-05E617C1-DEC2-4FF9-898B-F1FC1F01000AQ37148139-0D7C0E38-35F6-4D90-9245-094B01223EF9Q37623044-1F09653A-5766-4E6C-84CB-FF747B6ED2C1Q37972703-7E16FF9C-7D47-4527-8DBF-313FB1066D09Q38216131-40C0F792-0998-4F89-9CE0-1C2BA1B2BE0FQ38252624-5FB1F1CE-B153-4D88-AE1A-294C35BB10D3Q38904571-6250B169-F563-45B2-952E-0494B46AF34DQ39318240-0241FFC8-4BF9-4AE4-AEE0-07B988F2ED4FQ41660235-35CAD9E1-7051-403B-A9FC-CEB7E914A214Q44019552-FE171FE0-3482-4E65-8E1C-A555EE160CDCQ50099281-47D79F98-2084-4092-9683-D2342F3310A9Q53251387-E19F0CDE-E826-4B24-BBDD-F5D401AF09DEQ54210798-C32AFC75-97AC-475E-B80B-601E1380E486Q55265466-E1895830-029E-446B-9509-EC5FF15BED5C
P2860
Development of a diagnostic microarray assay to assess the risk of recurrence of prostate cancer based on PITX2 DNA methylation.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Development of a diagnostic mi ...... ased on PITX2 DNA methylation.
@en
type
label
Development of a diagnostic mi ...... ased on PITX2 DNA methylation.
@en
prefLabel
Development of a diagnostic mi ...... ased on PITX2 DNA methylation.
@en
P2093
P2860
P1476
Development of a diagnostic mi ...... ased on PITX2 DNA methylation.
@en
P2093
Antje Lukas
Arndt Hartmann
Dimo Dietrich
Glen Kristiansen
Gunter Weiss
Ina Fuhrmann
John Corman
Matthias Burger
Matthias Schuster
Philipp Schatz
P2860
P304
P356
10.2353/JMOLDX.2010.090088
P577
2010-03-19T00:00:00Z